These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7277132)

  • 1. Particulate inspection of parenteral products: an assessment.
    Knapp JZ; Kushner HK; Abramson LR
    J Parenter Sci Technol; 1981; 35(4):176-85. PubMed ID: 7277132
    [No Abstract]   [Full Text] [Related]  

  • 2. Particulate matter in parenteral products: a review.
    Borchert SJ; Abe A; Aldrich DS; Fox LE; Freeman JE; White RD
    J Parenter Sci Technol; 1986; 40(5):212-41. PubMed ID: 3540253
    [No Abstract]   [Full Text] [Related]  

  • 3. Particulate inspection of parenteral products: from biophysics to automation.
    Knapp JZ; Kushner HK
    J Parenter Sci Technol; 1982; 36(3):121-7. PubMed ID: 7097455
    [No Abstract]   [Full Text] [Related]  

  • 4. A model particulate research laboratory: I. Characterization of glass for parenteral products.
    Scothorn WW; Roseman TJ; Hamlin WE
    Bull Parenter Drug Assoc; 1976; 30(3):105-17. PubMed ID: 1268429
    [No Abstract]   [Full Text] [Related]  

  • 5. Particulate contamination in New Zealand intravenous solutions.
    Passl WJ; Waring JM
    N Z Med J; 1980 Mar; 91(655):177-9. PubMed ID: 6929987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calling it 'multidose' doesn't make it so: inappropriate sharing and contamination of parenteral medication vials.
    Schaefer MK; Shehab N; Perz JF
    Am J Infect Control; 2010 Sep; 38(7):580-1. PubMed ID: 20736116
    [No Abstract]   [Full Text] [Related]  

  • 7. [Possibilities of material contamination due to additional injections].
    Müller-Stock A
    Klin Anasthesiol Intensivther; 1977; (14):114-20. PubMed ID: 926677
    [No Abstract]   [Full Text] [Related]  

  • 8. [Possibilities of material contamination due to additional injections].
    Mehrkens HH; Klaus E; Schmitz JE
    Klin Anasthesiol Intensivther; 1977; (14):106-13. PubMed ID: 926676
    [No Abstract]   [Full Text] [Related]  

  • 9. Particulate contamination of parenterals.
    Dando W
    Anesth Prog; 1979; 26(5):127-8. PubMed ID: 298460
    [No Abstract]   [Full Text] [Related]  

  • 10. Parenteral fundamentals. Dynamics of microbial growth and death in parenteral products.
    Akers MJ
    J Parenter Drug Assoc; 1979; 33(6):372-88. PubMed ID: 261589
    [No Abstract]   [Full Text] [Related]  

  • 11. Panel discussion: particulate matter. 3. Electronic inspection.
    Levine S
    Bull Parenter Drug Assoc; 1966; 20(2):33-4. PubMed ID: 5905225
    [No Abstract]   [Full Text] [Related]  

  • 12. Panel discussion: particulate matter. II. Visual inspection.
    Saylor HM
    Bull Parenter Drug Assoc; 1966; 20(2):31-3. PubMed ID: 5905224
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the influence of open and closed-ampoule technologies on particulate matter in small-volume parenterals.
    Bernuzzi M; Raggi P; Montanari L; Pregnolato F; Pavanetto F
    J Parenter Sci Technol; 1993; 47(5):265-9. PubMed ID: 8263664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Particulate matter in I.V. infusion fluids.
    Davis NN; Turco S; Sivelly E
    Bull Parenter Drug Assoc; 1970; 24(6):257-70. PubMed ID: 5495399
    [No Abstract]   [Full Text] [Related]  

  • 15. Depyrogenation of a parenteral solution by ultrafiltration.
    Abramson D; Butler LD; Chrai S
    J Parenter Sci Technol; 1981; 35(1):3-7. PubMed ID: 7229828
    [No Abstract]   [Full Text] [Related]  

  • 16. A study of particulate matter in I.V. infusion fluids.
    Davis NM; Turco S; Sivelly E
    Am J Hosp Pharm; 1970 Oct; 27(10):822-6. PubMed ID: 5473472
    [No Abstract]   [Full Text] [Related]  

  • 17. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association.
    J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417
    [No Abstract]   [Full Text] [Related]  

  • 18. [Safe management of injections and parenteral infusions: recommendations of a new American guideline are not transferable to Germany].
    Panknin HT
    Kinderkrankenschwester; 2011 Apr; 30(4):157-9. PubMed ID: 21744569
    [No Abstract]   [Full Text] [Related]  

  • 19. [Filter systems for the prevention of material and bacterial contamination].
    Ahnefeld FW; Dick W
    Klin Anasthesiol Intensivther; 1977; (14):131-8. PubMed ID: 926679
    [No Abstract]   [Full Text] [Related]  

  • 20. Automatic particle counters used for regulatory monitoring of particulates in LVPs: statistical analysis.
    Oxborrow GS; Nierman ML; Heisick JE; Lanier JM
    J Parenter Sci Technol; 1981; 35(5):237-41. PubMed ID: 7299600
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.